Neuronal age drives β-sheet accumulation and, together with ApoE4, enhances synaptic Aβ localization in APPNL-F neurons
Konings, S. C.; Nyberg, E.; Martinsson, I. S.; Thakore, R.; Gouras, G. K.; Klementieva, O.
Show abstract
Amyloid-{beta} (A{beta}) accumulation and aggregation are defining features of Alzheimers disease (AD), but the earliest cellular events driving these processes remain poorly understood. Here, we investigate A{beta} dynamics in primary neurons derived from APPNL-F knock-in mice, which express human APP and A{beta} at endogenous (non-overexpressed) levels. Using correlative optical photothermal infrared (OPTIR) spectromicroscopy and immunofluorescence, we show that physiological APPNL-F expression is sufficient to drive intraneuronal A{beta} accumulation at synapses. Modelling neuronal aging through prolonged culture reveals a marked increase in synaptic A{beta} burden accompanied by {beta}-sheet-rich structural transitions Supplementation with astrocyte-derived apolipoprotein E (ApoE) isoforms demonstrates that ApoE4 markedly increases synaptic A{beta} accumulation while reducing {beta}-sheet content relative to untreated cultures, suggesting a potential shift toward less fibrillar species. Together, these findings establish APPNL-F neurons as a physiologically relevant system for dissecting early A{beta} pathology and show that both A{beta} quantity (accumulation) and quality (structural maturation) are regulated by aging and ApoE genotype. This work provides mechanistic insight into the earliest molecular events that may underlie synaptic vulnerability in AD.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tau phosphorylated at serine 356 is associated with Alzheimer's disease pathology and can be lowered in mouse and human brain tissue using the NUAK inhibitor WZ4003 96%
- Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease 96%
- Low circulating choline, a modifiable dietary factor, is associated with the pathological progression and metabolome dysfunction in Alzheimers disease. 96%
Similar papers in this journal
- Emergence of distinct and heterogeneous strains of amyloid beta as Alzheimer s disease progresses in Down syndrome 95%
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 95%
- C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimers disease 95%
Similar papers in this journal
- β-Amyloid Induces Microglial Expression of GPC4 and APOE Leading to Increased Neuronal Tau Pathology and Toxicity 96%
- APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology 95%
- A Trem2*R47H mouse model without cryptic splicing drives age- and disease-dependent tissue damage and synaptic loss in response to plaques 95%
Similar papers in this journal
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
- Immune receptor LAG3 regulates microglia function duringAlzheimer's disease 94%
- An interim exploratory biomarker analysis of a Phase 2 clinical trial to assess the impact of CT1812 in Alzheimers disease 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.